Nisa Investment Advisors’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $170K | Buy |
2,083
+943
| +83% | +$68.1K | ﹤0.01% | 1312 |
|
|
2026
Q1 | $77.7K | Buy |
1,140
+63
| +6% | +$4.46K | ﹤0.01% | 1519 |
|
|
2025
Q4 | $81.8K | Buy |
1,077
+79
| +8% | +$5.74K | ﹤0.01% | 1493 |
|
|
2025
Q3 | $61.2K | Hold |
998
| – | – | ﹤0.01% | 1575 |
|
|
2025
Q2 | $48.7K | Buy |
998
+71
| +8% | +$3.37K | ﹤0.01% | 1594 |
|
|
2025
Q1 | $47.2K | Sell |
927
-9
| -1% | -$449 | ﹤0.01% | 1604 |
|
|
2024
Q4 | $42.3K | Buy |
936
+109
| +13% | +$4.67K | ﹤0.01% | 1730 |
|
|
2024
Q3 | $30.7K | Buy |
827
+54
| +7% | +$1.81K | ﹤0.01% | 1775 |
|
|
2024
Q2 | $23.6K | Buy |
773
+44
| +6% | +$1.43K | ﹤0.01% | 1890 |
|
|
2024
Q1 | $21.2K | Buy |
729
+83
| +13% | +$2.33K | ﹤0.01% | 1867 |
|
|
2023
Q4 | $17.8K | Sell |
646
-2,010
| -76% | -$46K | ﹤0.01% | 1912 |
|
|
2023
Q3 | $59.5K | Buy |
2,656
+2,019
| +317% | +$75.1K | ﹤0.01% | 1671 |
|
|
2023
Q2 | $25.9K | Sell |
637
-1,033
| -62% | -$50.5K | ﹤0.01% | 1999 |
|
|
2023
Q1 | $81K | Sell |
1,670
-381
| -19% | -$17.4K | ﹤0.01% | 1568 |
|
|
2022
Q4 | $78K | Sell |
2,051
-463
| -18% | -$19.2K | ﹤0.01% | 1643 |
|
|
2022
Q3 | $99K | Buy |
2,514
+518
| +26% | +$25.4K | ﹤0.01% | 1509 |
|
|
2022
Q2 | $80K | Buy |
1,996
+121
| +6% | +$4.24K | ﹤0.01% | 1566 |
|
|
2022
Q1 | $70K | Sell |
1,875
-2,690
| -59% | -$104K | ﹤0.01% | 1742 |
|
|
2021
Q4 | $184K | Buy |
4,565
+1,180
| +35% | +$45.2K | ﹤0.01% | 1301 |
|
|
2021
Q3 | $126K | Hold |
3,385
| – | – | ﹤0.01% | 1599 |
|
|
2021
Q2 | $143K | Buy |
3,385
+850
| +34% | +$36.4K | ﹤0.01% | 1539 |
|
|
2021
Q1 | $120K | Hold |
2,535
| – | – | ﹤0.01% | 1674 |
|
|
2020
Q4 | $155K | Buy |
2,535
+400
| +19% | +$23.6K | ﹤0.01% | 1578 |
|
|
2020
Q3 | $100K | Buy |
2,135
+1,650
| +340% | +$81.2K | ﹤0.01% | 1546 |
|
|
2020
Q2 | $25K | Buy |
485
+25
| +5% | +$1.23K | ﹤0.01% | 1735 |
|
|
2020
Q1 | $21K | Buy |
460
+160
| +53% | +$8.06K | ﹤0.01% | 1702 |
|
|
2019
Q4 | $14K | Hold |
300
| – | – | ﹤0.01% | 1766 |
|
|
2019
Q3 | $10K | Hold |
300
| – | – | ﹤0.01% | 1784 |
|
|
2019
Q2 | $14K | Hold |
300
| – | – | ﹤0.01% | 1669 |
|
|
2019
Q1 | $11K | Hold |
300
| – | – | ﹤0.01% | 1724 |
|
|
2018
Q4 | $10K | Hold |
300
| – | – | ﹤0.01% | 1654 |
|
|
2018
Q3 | $14K | Hold |
300
| – | – | ﹤0.01% | 1628 |
|
|
2018
Q2 | $10K | Sell |
300
-7,500
| -96% | -$234K | ﹤0.01% | 1741 |
|
|
2018
Q1 | $201K | Sell |
7,800
-2,200
| -22% | -$55.7K | ﹤0.01% | 1238 |
|
|
2017
Q4 | $167K | Hold |
10,000
| – | – | ﹤0.01% | 1304 |
|
|
2017
Q3 | $200K | Hold |
10,000
| – | – | ﹤0.01% | 1249 |
|
|
2017
Q2 | $125K | Buy |
+10,000
| New | +$135K | ﹤0.01% | 1322 |
|
|
2016
Q2 | – | Sell |
-600
| Closed | -$4K | – | 1881 |
|
|
2016
Q1 | $4K | Buy |
+600
| New | +$10.4K | ﹤0.01% | 1847 |
|
Other funds holding PTCT
RI
JT
Nisa Investment Advisors's PTCT Position: Q2 2026 in Review
Nisa Investment Advisors increased its PTC Therapeutics (PTCT) stake by 83% in Q2 2026, buying an estimated $68.1K and bringing the position to 2,083 shares worth $170K. The position accounts for ﹤0.01% of the portfolio, ranked #1312.
Nisa Investment Advisors first reported a position in PTCT in Q1 2016 and has held it in 38 quarters since. The position peaked at $201K in Q1 2018. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.
- Nisa Investment Advisors held 2,083 shares of PTC Therapeutics worth $170K as of Q2 2026.
- Nisa Investment Advisors bought 943 PTC Therapeutics shares in Q2 2026, an estimated $68.1K.
- PTC Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1312 holding.
- Nisa Investment Advisors first reported a position in PTC Therapeutics in Q1 2016 and has held it in 38 quarters since.
- Nisa Investment Advisors's PTC Therapeutics position peaked at $201K in Q1 2018.
- 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.
Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.